Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Asian Stocks Up, but Focus Remains on Inflation

Published 04/13/2021, 11:17 PM
Updated 04/13/2021, 11:26 PM
© Reuters.

By Gina Lee

Investing.com – Asia Pacific stocks were mostly up Wednesday morning, with investors brushing off a higher-than-expected rise in U.S. inflation to focus on the global economic recovery from COVID-19.

China’s Shanghai Composite inched up 0.01% by 11:12 PM ET (3:12 AM GMT) and the Shenzhen Component jumped 1.36%. Wednesday’s March trade data, including exports, imports and the trade balance, continued to give Chinese shares a boost. Further data, including GDP, industrial production and fixed asset investment, is due on Friday.

Credit markets are monitoring a sharp selloff in China Huarong Asset Management Co. Ltd. (HK:2799), one of the country’s largest distressed debt managers. The selloff triggered concerns that other heavily leveraged borrowers could also stumble.

Hong Kong’s Hang Seng Index rose 0.96%.

Japan’s Nikkei 225 was down 0.45%, amid concerns a slower-than-expected COVID-19 vaccine rollout will limit activity. Data on Japanese core machinery orders, released earlier in the day, also disappointed. February’s core machinery orders contracted 7.1% year–on–year, against the 2.3% growth in forecasts prepared by Investing.com and January’s 1.5% growth. Orders contracted 8.5% month-on-month.

South Korea’s KOSPI inched up 0.01% and in Australia, the ASX 200 rose 0.32%.

In the U.S., data released on Tuesday said that the core consumer price index (CPI) rose 0.3% month-on-month in March, against the 0.2% growth in forecasts and February’s 0.1% growth. The CPI grew 0.6% month-on-month.

The higher-than-expected numbers seemed to have little impact, however, given that the distortions surrounding the slump in price pressures in 2020. Some investors also remained confident that recovery will continue as central banks and government spending continue to provide support.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

“A lot of growth and inflation has already been priced into the market... it’s almost as if you need to exceed those expectations in order to see a more pronounced reaction from markets,” John Hancock Investment Management co-chief investment strategist Emily Roland told Bloomberg.

Investors also continue to monitor U.S. Treasury yields, which extended gains following a successful auction of 30-year bonds as fears that poor demand could spark another bout of volatility were assuaged.

However, runaway inflation, along with higher borrowing costs and taxes, replaced COVID-19 as the top concern for global fund managers, according to the latest Bank of America Corp (NYSE:BAC). survey.

U.S. Federal Reserve Chairman Jerome Powell will speak at an Economic Club of Washington event later in the day when the central bank will also release its Beige Book.

Meanwhile, in a blow to the global COVID-19 vaccine rollout, the U.S. Centers for Disease Control and Prevention and FDA halted the use of the Johnson & Johnson (NYSE:JNJ) vaccine on Tuesday. The pause comes after six women who received it developed a rare and severe form of blood clotting and is expected to last for a few days.

In cryptocurrencies, bitcoin reached a record high and the Nasdaq set a reference price of $250 for the direct listing of cryptocurrency exchange Coinbase Global Inc. that starts trading later in the day.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.